HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Hettiarachchi Selected Research

CP 122288

2/2000No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: results of two randomized, double-blind, placebo-controlled clinical trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Hettiarachchi Research Topics

Disease

4Headache (Headaches)
02/2005 - 02/2002
4Migraine Disorders (Migraine)
02/2005 - 02/2002
1Epilepsy (Aura)
10/2004
1Coronary Artery Disease (Coronary Atherosclerosis)
07/2004
1Pain (Aches)
02/2002
1Neurogenic Inflammation
02/2000

Drug/Important Bio-Agent (IBA)

5eletriptan (Relpax)FDA Link
02/2005 - 02/2002
2Sumatriptan (Imigran)FDA LinkGeneric
02/2005 - 07/2004
2Pain-FreeIBA
02/2005 - 11/2003
1Tryptamines (Triptans)IBA
10/2004
1naratriptanFDA LinkGeneric
11/2003
1CP 122288IBA
02/2000

Therapy/Procedure

1Aftercare (After-Treatment)
02/2002